Indo Us Biotech Limited Stock Price Today (NSE: INDOUS)

Indo Us Biotech Limited

77.161.13 (1.44%)
Market Closed

Fundamental Score

...

Indo Us Biotech Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Indo Us Biotech Limited share price today is 77.16, down 1.44% on NSE/BSE as of 16 September 2026. Indo Us Biotech Limited (INDOUS) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 154.72 (Cr). The 52-week high for INDOUS share price is 159.00 and the 52-week low is 70.00. At a P/E ratio of 13.54x, INDOUS is currently trading below its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 15.34% and a debt-to-equity ratio of 0.40.

Indo Us Biotech Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
90.88
Low
70.00
Volume
16.0K
Change
-2.38%

Indo Us Biotech Limited share price chart: -2.38% return over the past month. 52-week high ₹159.00, 52-week low ₹70.00.

Indo Us Biotech Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
81.0081.0076.1077.163.84K (Cr)
79.9081.0076.0078.292.24K (Cr)
82.0082.0078.0078.2410.16K (Cr)
81.2081.2578.0179.545.67K (Cr)
81.3381.3378.0080.2518.72K (Cr)
78.8183.0078.0578.8513.63K (Cr)
77.4879.9575.9678.745.68K (Cr)
77.0279.7870.0077.4841.73K (Cr)
78.1581.9978.1578.823.58K (Cr)
79.0081.3076.0578.155.09K (Cr)

Indo Us Biotech Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
82.7284.2770.0077.16-6.72%
81.0090.8874.9879.47-1.89%
88.8891.9080.1081.62-8.17%
98.00103.8486.1687.59-10.62%
106.95114.0098.1399.80-6.69%
99.00112.0099.00104.27+5.32%
142.94148.0096.0598.21-31.29%
120.00154.39120.00144.56+20.47%
124.00133.00105.00125.22+0.98%
133.42151.00118.00121.56-8.89%
135.35159.00109.50135.42+0.05%
140.00144.59119.39134.31-4.06%

Returns & Performance

Average

Return on Equity (ROE)

15.34%

Profit generated per ₹1 of shareholder equity

Good

Return on Capital (ROCE)

18.46%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

15.56%

Average operating profit margin over 5 years

Dividend Yield

0.29%

Annual dividend as % of current share price

Indo Us Biotech Limited Valuation Check

Good

Price to Earnings (P/E)

13.54x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.03x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.17%

% shares held by company founders/management

Poor

FII Holding

0.01%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-35.41%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

7.21%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

22.91%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

13.17%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

20.75%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.40x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

7.21x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-16.07 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Indo Us Biotech Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of INDOUS across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (15.34%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (18.46%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (15.56%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 13.54 vs Industry: 19.03)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (22.91% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (20.75% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (7.21x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 5.31)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (70.17%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Profit Decline Concern (-35.41%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Negative Free Cash Flow (₹-16.07 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.01%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Indo Us Biotech Limited vs Other Agricultural Products Peers

Peer Comparison - Other Agricultural Products

Compare Indo Us Biotech Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
47.6/100
77
₹154.72
13.5
Average
15.34%
Good
18.46%
Good
0.4
Excellent
20.75%
Excellent
22.91%
Excellent
0.29%
59.6/100
454
₹15749.66
24.6
Average
0.00%
Poor
20.11%
Excellent
0.2
Excellent
17.99%
Excellent
18.70%
Excellent
0.78%
45.2/100
434
₹9944.56
13.1
Average
11.73%
Average
15.54%
Good
0.0
Excellent
2.95%
Average
8.84%
Good
0.97%
45.1/100
166
₹7632.31
18.3
Average
9.66%
Poor
13.10%
Average
0.1
Excellent
-2.08%
Poor
4.01%
Average
0.17%
51.8/100
722
₹3714.15
15.0
Average
18.17%
Good
18.21%
Good
0.0
Excellent
-0.96%
Poor
6.12%
Good
0.59%
39.7/100
109
₹2182.52
45.4
Average
5.09%
Poor
5.51%
Poor
0.0
Excellent
19.99%
Excellent
19.85%
Excellent
0.00%
40.4/100
88
₹1826.35
13.9
Average
14.47%
Average
23.69%
Excellent
0.6
Good
10.46%
Good
18.11%
Excellent
0.00%
54.6/100
305
₹1517.64
12.1
Average
14.61%
Average
19.04%
Good
0.1
Excellent
6.96%
Good
11.07%
Good
0.89%
58.2/100
92
₹1407.41
16.8
Average
0.00%
Poor
16.93%
Good
0.2
Excellent
7.57%
Good
8.01%
Good
1.13%
58.1/100
180
₹1121.80
7.6
Average
16.09%
Good
21.93%
Excellent
0.4
Excellent
11.40%
Good
24.73%
Excellent
0.17%
53.4/100
89
₹938.35
32.4
Average
22.68%
Excellent
29.10%
Excellent
0.8
Good
35.75%
Excellent
14.96%
Good
0.00%

Indo Us Biotech Limited PE Ratio History

Historical price-to-earnings ratio for INDOUS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20258.12₹121.5615x
FY 20244.11₹314.9076.6x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Indo Us Biotech Limited Dividend History

Annual cash dividends paid by INDOUS — dividend yield 0.29%

Financial YearDividends Paid (₹ Cr)
FY 20250.50 Cr
FY 20220.15 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Indo Us Biotech Limited Quarterly Performance

Latest quarterly metrics for INDOUS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

7.21%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-35.41%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

22.91%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

20.75%

Compounded annual net profit growth over 5 years

Indo Us Biotech Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for INDOUS — calculated from daily price history

18RSI 14
Oversold — RSI 18

Selling pressure is heavy — potential reversal zone.

SMA 50
84
▼ Price below SMA 50 — Short-term bearish
SMA 200
107
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
19K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Indo Us Biotech Limited Financial Statements

Annual income statement, balance sheet and cash flow for Indo Us Biotech Limited (INDOUS) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Indo Us Biotech Limited

Loading latest quarterly results...

About INDOUS (Indo Us Biotech Limited)

Indo US Bio Tech Ltd is a pioneering force in India's agricultural landscape, specializing in the creation and distribution of high-quality seeds. The company meticulously oversees... every stage, from the initial cultivation and careful processing to the specialized packaging and strategic marketing of its diverse seed portfolio. INDOUS is committed to providing farmers with superior genetic resources, ensuring bountiful harvests and contributing to the nation's food security. They are the backbone of farming communities, constantly innovating to meet the evolving needs of the agricultural industry and setting new standards for seed excellence. Offering a wide spectrum of seed varieties, INDOUS caters to the diverse needs of Indian farmers. Their extensive selection includes a vibrant array of vegetable seeds, from the staple tomato and okra to the more exotic bottle gourd and bitter gourd. In addition to vegetables, INDOUS cultivates and distributes seeds for essential cash crops such as cotton, and vital oilseeds including castor, groundnut, and soybean. The company's commitment to research and development ensures that these seeds are not only high-yielding but also resilient to various environmental challenges, supporting sustainable agricultural practices across the country. Beyond simply selling seeds, INDOUS provides a comprehensive support system for farmers. They believe in empowering the agricultural community through knowledge sharing and innovative solutions. By offering access to premium seeds and practical expertise, INDOUS helps farmers increase their productivity, improve crop quality, and enhance their overall livelihoods. The company actively participates in initiatives that promote sustainable farming practices, contributing to a greener and more prosperous future for Indian agriculture.

Company Details

Symbol:INDOUS
Industry:Other Agricultural Products
Sector:Other Agricultural Products

Key Leadership

Mr. Jagdishkumar Devjibhai Ajudia
Chairman & MD
Ms. Rinku Dipenbhai Jethva
Chief Finance Officer
Ms. Dimpy Divyangbhai Joshi
Company Secretary & Compliance Officer

INDOUS Share Price: Frequently Asked Questions

What is the current share price of Indo Us Biotech Limited?

Indo Us Biotech Limited (INDOUS) trades at ₹77.16 on NSE and BSE. Market cap ₹154.72 (Cr). Educational data only.

What is the P/E ratio of Indo Us Biotech Limited?

Indo Us Biotech Limited has a P/E of 13.54x vs industry average 19.03x.

What is the Bull Run score for Indo Us Biotech Limited?

Indo Us Biotech Limited has a Bull Run score of 47.6/100 based on 25+ financial parameters.

Does Indo Us Biotech Limited pay dividends?

Indo Us Biotech Limited has a dividend yield of 0.29%. Past dividends don't guarantee future payments.

What is the ROE of Indo Us Biotech Limited?

Indo Us Biotech Limited has ROE of 15.34%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Indo Us Biotech Limited?

Indo Us Biotech Limited has debt-to-equity of 0.40.

Is Indo Us Biotech Limited a good investment?

Bull Run gives Indo Us Biotech Limited a score of 47.6/100. This is not investment advice — consult a SEBI-registered advisor.